How can a pilot stage be equipped without judging the machine solely by its maximum capacity? This question provides a way to examine the Sepion 75, the tablet coating system presented by Syntegon on 19 August 2026.
The manufacturer describes a coater with two interchangeable drum sizes, covering batch volumes from 8 to 75 litres. Its stated objective is to maintain consistent process principles when moving from pilot to commercial scale. Closed material handling is provided, and the series offers optional containment configurations up to OEB5. These features are reported in the company's announcement; they do not constitute verification of performance on a user's product. Official source.
The capacity to buy depends on the batches
For Economind, the economic comparison starts with the intended production programme. We suggest listing the products to be developed, the volumes needed for trials and the frequency of changeovers. This framework would allow discussion with the supplier about which part of the available capacity meets an actual requirement.
The comparison between offers should also include time spent on preparation, cleaning and data collection. We do not have comparative measurements for this machine: these are items to request and verify, not already demonstrated economic benefits. The same applies to the potential value of performing several activities on the same platform.
Scale-up must be demonstrated
Design consistency within a machine family is something to investigate during process trials. Economind proposes asking which parameters remain comparable, which require adaptation and what evidence is available for the product concerned. A commercial description alone does not answer these questions.
Before judging the return on investment, test conditions, configuration costs and a utilisation plan are needed. Optional containment must also be assessed against the specific supply. The Sepion 75 case provides a basis for discussing pilot-stage flexibility; it does not establish standard savings or results valid for every pharmaceutical process.
Editorial transparency
This article was prepared with AI assistance using the official announcement. Results and features are attributed to the manufacturer. No site visits or independent tests were carried out.
Originally published on 24 October 2026. English translation prepared with AI assistance on 24 October 2026.